EUVIMEDEUVIMED entdecken
Open Access

The Role of Salvage Chemotherapy on Survival Outcomes Following Immune Checkpoint Inhibitor Therapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

Daisuke Abe, Takayuki Kimura, Satoru Koike, Hisatomo Tamaki, Sayumi Konya, Maya Kawamoto, Masahiro Umemoto, Mitsuo Sato, Mutsukazu Kitano, Takahiro Wakasaki, Ryuji Yasumatsu

In Vivo · 2025

DOI: 10.21873/invivo.14100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2025. Verfasst von Daisuke Abe und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Kindai University, Faculty of Medicine, Osaka-Sayama, Japan. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Salvage Therapy, Squamous Cell Carcinoma of Head and Neck, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsSalvage TherapySquamous Cell Carcinoma of Head and NeckNeoplasm Recurrence, LocalHead and Neck NeoplasmsHumansMaleFemaleMiddle AgedAgedRetrospective StudiesAdultNeoplasm MetastasisTreatment OutcomePrognosisAntineoplastic Combined Chemotherapy ProtocolsAged, 80 and overNivolumab

Stichwörter der Autor:innen

Head and neck squamous cell carcinomaimmune checkpoint inhibitorsperformance statussalvage chemotherapysarcopenia

Substanzen

Immune Checkpoint InhibitorsNivolumab

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Kindai University, Faculty of Medicine, Osaka-Sayama, Japan.
  • Department of Otolaryngology-Head and Neck Surgery, Kindai University, Faculty of Medicine, Osaka-Sayama, Japan ryuji.yasumatsu@med.kindai.ac.jp.

Zitieren

APA

Abe, D., Kimura, T., Koike, S., Tamaki, H., Konya, S., Kawamoto, M., Umemoto, M., Sato, M., Kitano, M., Wakasaki, T., & Yasumatsu, R. (2025). The Role of Salvage Chemotherapy on Survival Outcomes Following Immune Checkpoint Inhibitor Therapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma. In Vivo. https://doi.org/10.21873/invivo.14100

Vancouver

Abe D, Kimura T, Koike S, Tamaki H, Konya S, Kawamoto M, et al. The Role of Salvage Chemotherapy on Survival Outcomes Following Immune Checkpoint Inhibitor Therapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma. In Vivo. 2025. doi:10.21873/invivo.14100

BibTeX
@article{Abe2025,
  author = {Abe, Daisuke and Kimura, Takayuki and Koike, Satoru and Tamaki, Hisatomo and Konya, Sayumi and Kawamoto, Maya and Umemoto, Masahiro and Sato, Mitsuo and Kitano, Mutsukazu and Wakasaki, Takahiro and Yasumatsu, Ryuji},
  title = {The Role of Salvage Chemotherapy on Survival Outcomes Following Immune Checkpoint Inhibitor Therapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma},
  journal = {In Vivo},
  year = {2025},
  doi = {10.21873/invivo.14100}
}
Kostenlos starten →